Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Moodys
Johnson and Johnson
McKinsey
McKesson

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

Patent Applications for TYGACIL

See Plans and Pricing

« Back to Dashboard

US Patent Applications for TYGACIL

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial SUBSTITUTED TETRACYCLINE COMPOUNDS AS SYNERGISTIC ANTIFUNGAL AGENTS 2002-03-14 Patented Case 2006-04-26
  Start Trial   Start Trial Methods of treating bacterial infections and diseases associated therewith 2003-05-22 Abandoned -- Failure to Respond to an Office Action 2013-04-22
  Start Trial   Start Trial Tetracycline compounds having target therapeutic activities 2002-07-15 Abandoned -- Failure to Respond to an Office Action 2004-03-17
  Start Trial   Start Trial Methods and compositions for treating bacterial infections and diseases associated therewith 2003-08-29 Expressly Abandoned -- During Examination 2009-01-05
  Start Trial   Start Trial Methods and reagents for treating infections of clostridium difficile and diseases associated therewith 2003-08-29 Abandoned -- Failure to Respond to an Office Action 2007-11-13
  Start Trial   Start Trial Methods for treating and preventing Gram-positive bacteremias 2003-09-04 Abandoned -- Failure to Respond to an Office Action 2008-02-04
  Start Trial   Start Trial Methods and reagents for preventing bacteremias 2003-08-25 Abandoned -- Failure to Respond to an Office Action 2007-10-01
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Harvard Business School
McKesson
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.